date:Apr 22, 2014
Given FDAs long to-do list, some are skeptical of whether the agency will take action to resolve the ECJ issue anytime soon.
As a practical matter, and now that it has reopened the comment period on the draft ECJ guidance, it is probable that FDA will not get to this for a very long time, if ever, particularly given other competing priorities in the food arena, Friede said.
So courts are dismissing ECJ cases on primary jurisdiction grounds, thanks to the reopened commenting period. Yet it seem